3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Non-Small Cell Lung Cancer ALK-positive
1
Neurofibromatosis 1
1
Hereditary Sensory and Autonomic Neuropathies
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
1
ALK Positive Non-small Cell Lung Cancer
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Methotrexate
3
Cyclophosphamide
3
ponatinib
2
merphos
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Busulfan
2
venetoclax
1
blinatumomab
1
Thiotepa
1
Sirolimus
1
Rituximab
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Injections
1
Etoposide
1
Decitabine
1
Cytarabine
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Accelerated Phase
×
lorlatinib
×
30 days
×
Clear all
No trials found.